Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review

Recruiting Observational Study
Transplant Kidney Diseases
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
240 (estimated)
Sponsor
Methodist Health System · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
1.1. Background: Renal transplantation is the treatment of choice for eligible patients with end-stage renal disease. It provides better outcomes in terms of life expectancy and quality of life than dialysis (Liu, Narins, Maley, Frank, \& Lallas, 2012). Kidney transplants from living donors also have additional benefits in terms of graft function and survival compared to transplants from cadaver d…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * ≥ 18 years of age * Kidney donors and recipients who underwent a hand-assisted or robotic kidney transplant Exclusion Criteria: * Patients that do not meet the Study Inclusion Criteria laid out above
Contacts

Crystee Cooper, DHEd

214-947-1280

clinicalresearch@mhd.com

CONTACT

Zaid Haddadin, MS

214-947-1280

clinicalresearch@mhd.com

CONTACT